Trial Profile
Pharmacokinetics and safety of human recombinant interleukin-1 receptor antagonist in healthyvolunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Nov 2018
Price :
$35
*
At a glance
- Drugs GR 007 (Primary)
- Indications Cancer
- Focus Adverse reactions; Pharmacokinetics
- 31 Oct 2018 Results published in the European Journal of Drug Metabolism and Pharmacokinetics
- 23 Mar 2018 New trial record